| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.071 | 0.2 |
| mRNA | Axitinib | FIMM | pan-cancer | AAC | 0.2 | 0.2 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.056 | 0.2 |
| mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | 0.058 | 0.2 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | 0.036 | 0.2 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.057 | 0.2 |